A Trial for Patients With Gestational Trophoblastic Disease
This phase II study is evaluating the activity of Pemetrexed in patients diagnosed with low risk Gestational Trophoblastic Tumor (GTT) that have failed prior treatment.
Trophoblastic Neoplasms|Uterine Neoplasms|Hydatidiform Mole|Choriocarcinoma
DRUG: Pemetrexed
To determine the activity of Pemetrexed in failed low risk Gestational Trophoblastic Tumor (GTT) patients
To determine the toxicity of Pemetrexed in failed low risk Gestational Trophoblastic Tumor (GTT) patients
This phase II study is evaluating the activity of Pemetrexed in patients diagnosed with low risk Gestational Trophoblastic Tumor (GTT) that have failed prior treatment.